Triple Crown Ventures

Triple Crown Ventures
Date: 2025
Deal: Acquisition of majority stake in Cannovum Health.
About the client: TCV is a specialist vehicle established to invest in and acquire businesses across the medical cannabis value chain.
About the transaction: Akur advised TCV on the acquisition of a majority stake in Cannovum Health, a licensed distributor of medical cannabis products in Germany.
Lead: David Shapton
<img alt=

Triple Crown Ventures

Triple Crown Ventures
Date: 2025
Deal: Investment into GROW Group plc
About the client: TCV is a specialist vehicle established to invest in and acquire businesses across the medical cannabis value chain.
About the transaction: Akur advised TCV on its investment into GROW Group plc, a licensed distributor of medical cannabis products in the UK, Germany and Australia.
Lead: David Shapton
<img alt=